Advertisement

Topics

AstraZeneca fights back in cancer with new hires, fast drug status

05:06 EDT 31 Jul 2017 | Reuters

LONDON (Reuters) - AstraZeneca hired two senior scientists to bolster its cancer drug work on Monday, signaling confidence in its oncology portfolio despite last week's big setback in a lung cancer clinical trial.

Original Article: AstraZeneca fights back in cancer with new hires, fast drug status

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca fights back in cancer with new hires, fast drug status"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...